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INTRODUCTION
Diabetic vascular complications shorten the lifespan and deterio-
rated the quality of life in patients with type 2 diabetes. To prevent
these complications, clinical application of useful marker for micro-
vascular and macro-vascular is necessary.
Non-enzymatic glycation of proteins is a series of complex and
sequential reactions collectively called the Maillard reaction. Early -
stage reactions lead to the formation of the early glycation adducts,
and later -stage reactions subsequently form advanced glycation
end-products (AGEs). Increased formation and accumulation of
AGEs could be a major pathogenic mechanism in developing athe-
rosclerosis in type 2 diabetes (1). The accumulation of AGEs on
tissue proteins has been implicated as a contributing factor in the
progression of diabetes complications (2-6).
Tissue AGEs accumulation may reflect the cumulative effect of
hyperglycemia over many years. Therefore, tissue AGEs accumu-
lation must represent the existing tissue damage resulting from
various known risk factors under diabetic condition (7). Skin auto-
fluorescence (AF) has a strong correlation with the specific AGEs
content in skin biopsies, as shown in multiple validation studies
(8-10). Simple quantitation of accumulated AGEs in the tissue could
provide a tool for assessing tissue injury and the risk of long-term
complications (8). Non- invasive measurement of AF has been pro-
posed as a marker of accumulation of AGEs in the skin (11). AF
is increased in patients with type 2 diabetes in conjunction with
macrovascular disease (9). Increased AF was reported to predict
cardiovascular events independent of conventional risk factors (12).
Carotid intima-media thickness (IMT) is an especially useful
marker of the progression of atherosclerosis throughout the body,
and is an excellent predictor of cardiovascular events. As a simple
and non- invasive procedure, measurement of carotid IMT is one
of the most appropriate screening methods to specify high-risk in-
dividuals in subjects with and without diabetes (13). It is reported
that elevated AF is associated with IMT in non-diabetic subjects
(14). So far, there are no reports describing about the relation be-
tween AF, IMT, and other clinical characteristics in patients with
type 2 diabetes.
The objective of this study is to investigate the correlation be-
tween AF, IMT, and other clinical characteristics in patients with
type 2 diabetes in a cross-sectional manner.
MATERIALS AND METHODS
This cross-sectional study was performed in Tenma Hospital,
Tokushima, Japan, from May to October in 2014. The present study
was carried out in accordance with the Declaration of Helsinki and
with approval from the ethical committee of Tenma Hospital. The
written informed consent was obtained from each patient. The in-
clusion criteria were patients with type 2 diabetes who were below
80 years old. The exclusion criteria was patients with moderate to
end-stage renal failure (eGFR30 ml/min/1.73 m2), anemia (he-
moglobin10 g/dl), and extremely sunburn. A total of 68 patients
who met the inclusion and exclusion criteria were consecutively
selected in this study. We also excluded individuals with unstable
retinopathy, pregnancy or using steroids. All patients were studied
after an overnight fast. BMI was calculated as weight divided by
height squared (in kgm-2). Waist circumstance was measured
between the 10th rib and the iliac crest.
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HbA1c was measured with high-performance liquid chromatog-
raphy method. HbA1c was expressed as a National Glycohemoglo-
bin Standardization Program (NGSP) equivalent value. Glycated
albumin was determined by an enzymatic method using a liquid
chemistry system (Lucica GA-L method, Asahi Kasei Corp., Tokyo).
For an assessment for urine albumin/creatinine ratio (UACR),
urine albumin and creatinine were measured from a single random
voided urine sample. Urine albumin levels were measured by im-
munoturbimetric assay (ALBT2, Roche, Basel, Switzerland). Urine
creatinine levels were measured using the Jaffe method (CREJ2,
Roche). Serum creatinine and lipid levels [total, high-density lipo-
protein (HDL), and low-density lipoprotein (LDL) cholesterol and
triglycerides] were measured immediately using standard methods.
Plasma pentosidine concentrations were measured using a commer-
cially available competitive enzyme-linked immunosorbent assay
(ELISA) (FSK pentosidine ELISA kit ; Fushimi Pharmaceutical,
Kagawa, Japan) ; the samples were stored at -80 until analysis.
Micro-albuminuria in the stage 2 of diabetic nephropathy and
macro-albuminuria in the stage 3 of diabetic nephropathy were
defined as the urinary albumin/creatinine excretion ratio more
than 30 and 300 mg/gCr, respectively. Retinopathy was diagnosed
as non-diabetic retinopathy (NDR), simple diabetic retinopathy
(SDR), and pre-proliferative retinopathy (PPDR) by ophthalmolo-
gists.
Measurement of AF
AF was measured with the advanced glycation end product
(AGE) ReaderTM (DiagnOptics Technologies BV, Groningen, the
Netherlands). The AGE Reader is a desktop device that uses the
characteristic fluorescent properties of some advanced glycation
end-products to estimate the level of advanced glycation end-
product accumulation in the skin. Technical and optical details of
this non- invasive method have been described more extensively
elsewhere (11). In short, the AGE Reader illuminates a skin surface
of 4 cm2, guarded against surrounding light, with an excitation light
source with a peak excitation of 370 nm. This wavelength is in the
UVA spectrum. Emission light in the wavelength range of 420-600
nm (fluorescence) and excitation light that is reflected by the skin
with a wavelength range of 300-420 nm from the skin is measured
with a spectrometer. Skin autofluorescence was determined from
the ratio between the emission light and the reflected excitation
light, using the AGE Reader software, version 2.2. AF was meas-
ured at room temperature while patients were at rest in a seated
position. The forearm was positioned on the top of device in the
usual manner, as described by the manufacturer. Measurements
were not specifically performed in a fasting state. For each skin
autofluorescence value, three consecutive measurements were
carried out at three different skin sites of the same forearm, within
a total test period of approximately 2 min. The mean of these three
consecutive measurements was used in the analyses. Skin pigmen-
tation influences the measurement of skin autofluorescence and its
influence has been extensively studied and reported earlier (15).
Measurement of max-IMT
IMT was measured by one laboratory technician in accordance
with a previous report (13). In brief, using B-mode ultrasonogra-
phy, the carotid arteries are scanned in transverse sections from the
origins of the common carotid arteries, carotid sinuses, internal ca-
rotid arteries and external carotid arteries, and then examined for
carotid lesions in longitudinal sections at different angles. High-reso-
lution ultrasound images with a range resolution of 0.1 mm can be
obtained when carotid ultrasonography is carried out using a linear
probe with a center frequency of 8.9 MHz (GM-72P00A, Panasonic
Healthcare Co. Japan) (13). Among IMT values, max-IMT is supe-
rior to mean-IMT in distinguishing patients with coronary stenosis
(13, 16, 17), thus max-IMT was measured in this study.
Statistical Analysis
Demographic data are presented as meansstandard deviation
(SD). Between-group differences of the average were compared
using Mann-Whitney U test for non-parametric data. Categorical
variables were compared using χ2 - test. Spearman’s analysis was
done for non-parametric variables. Stepwise regression analysis was
indicated to AF and age. For statistical analyses were performed
with SPSS version 22.0 software. For all tests, p0.05 was consid-
ered statistically significant.
RESULTS
The data was successfully measured in 61 patients among 68
patients. The characteristics of these study participants were shown
in Table 1. Treatment for diabetes was diet alone in 9 patients, oral
hypoglycemic agents (OHA) in 40 patients, and insulin with and
without OHA in 7 and 5 patients. Thirty three patients and 21 pa-
tients were treated by anti -hypertensive agents and lipid- lowering
agents, respectively. SDR and PPDR were observed in 5 patients,
respectively. Fourteen patients were in the stage 2 and three were
in the stage 3 of diabetic nephropathy.
Because the data are not normally distributed, Spearmann’s non-
parametric test was applied to the statistical analyses. The corre-
lations between max-IMT, AF and clinical characteristics were
shown in Table 2. AF was significantly correlated with age (r=
0.560, p0.0001), duration of diabetes (r=0.256, p0.05), serum
creatinine (r=0.264, p0.05), and max-IMT (r=0.407, p0.001,
Figure 1). Max-IMT also tended to be correlated with age (r=
0.249, p=0.053). Multivariate regression analysis using AF and age
for the dependent factor revealed that AF was only an independent
determinant of max-IMT (R=0.425, β=0.425, p0.01).
In addition, AF was significantly higher in patients with diabetic
Table 1. Patients’ Characteristics
Number of subjects 61
Gender (male/female) 38/23
Age (years) 66.69.2
Duration of diabetes (years) 10.47.3
BMI(kg/m2) 25.54.6
Systolic blood pressure (mmHg) 130.715.5
Diastolic blood pressure (mmHg) 70.99.3
HbA1c (%) 7.00.8
Glycated albumin (%) 17.92.7
Pentosidine (μl/mL) 0.0320.017
Creatinine (mg/dL) 0.720.16
eGFR (ml/min/1.73 m2) 78.922.9
UAER (mg/gCr) 55.1161.4








BMI ; body mass index, eGFR ; estimated glomerular filtration rate,
UAER ; urinary albumin excretion rate, AF ; autofluorescence, NDR ; non-
diabetic retinopathy, SDR ; simple diabetic retinopathy, PPDR ; pre -
proliferative retinopathy, Max-IMT ; maxim intima-media thickness in
the carotid artery.
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retinopathy (SDR or PPDR) compared to the patients without dia-
betic retinopathy (3.030.67 vs 2.410.40, p0.01). There was no
significant difference of AF between with and without diabetic
nephropathy (2.460.43 vs 2.630.63, n.s.).
DISCUSSION
The present study showed that subcutaneous accumulation of
AGE was well correlated with the degree of max-IMT of the ca-
rotid artery. On the other hand, HbA1c, glycated albumin, and
pentosidine were not correlated with max-IMT.
Increased AGE-RAGE signal was a major cause of atherosclero-
sis in patients with diabetes. Since pathological change of athero-
sclerosis progresses gradually, short duration of glycated protein,
such as HbA1c and glycated albumin, were unable to reflect it.
Measurement of tissue AGEs may be preferable over plasma meas-
urement, since long- lived proteins accumulate in the tissues in
which chronic complications develop (18). Thus, blood and urine
AGEs do not necessarily reflect their tissue levels (19). Indeed,
pentosidine, a fluorescent advanced glycation product, was also
reported to correlate well with AF (8), however, there are no cor-
relation between serum pentosidine and max-IMT and AF. We also
failed to find the correlation between max-IMT and pentosidine in
this study.
Previous reports have shown that increased accumulation of AGE
in tissue was a major cause of micro-vascular complications (2-6).
In the present study, subcutaneous accumulation of AGEs was
correlated with the presence of diabetic retinopathy, but not dia-
betic nephropathy. Because the development and progression of
kidney injury in diabetic patients were not only due to chronic
hyperglycemia, but also hypertension, smoking, obesity, and use
of renin-angiotensin inhibitor, we failed to observe the correlation
between AF and nephropathy, as reported previously (20,21). As
mentioned, renal failure is not only because of hyperglycemia, we
excluded patients with end-stage renal failure in this study. In ad-
dition, renal failure itself is known to increase AGEs formation.
There are some limitations in our study. The number of the pa-
tients seems small to conclude in this cross-sectional study, how-
ever, it was enough to find the correlation between the AF and
max-IMT. We usually use mean-IMT and max-IMT values to
evaluate atherosclerosis in patients with type 2 diabetes. The IMT
value is only evaluated with max-IMT in this study. We experi-
enced that max-IMT represents better than mean-IMT in evalu-
ation of the atherosclerosis in patients with type 2 diabetes (16, 17).
In conclusion, non- invasive measurement of AF might be a good
surrogate marker for evaluating atherosclerosis and micro-an-
giopathy in patients with type 2 diabetes.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest asso-
ciated with the present study.
ACKNOWLEDGMENTS
We acknowledge Kazumi Hata for excellent secretarial work.
REFERENCES
1. Goldin A, Beckman JA, Schmidt AM, Creager MA : Advanced
glycation end products. Sparking the development of diabetic
vascular injury. Circulation 114 : 597-605, 2006
2. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S,
Brinck-Johnsen T, Bucala R, Vlassara H : Formation of im-
munochemical advanced glycosylation end products precedes
and correlates with early manifestations of renal and retinal
disease in diabetes. Diabetes 44 : 824-829, 1995
3. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance
DR, Baynes JW : Accumulation of Maillard reaction products
in skin collagen in diabetes and aging. J Clin Invest 91 : 2463-
2469, 1993
4. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR,
Baynes JW, Lyons TJ : Maillard reaction products and their
relation to complications in insulin-dependent diabetes mel-
litus. J Clin Invest 91 : 2470-2478, 1993
5. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot
P, Kohn RR : Relation between complications of type I diabe-
tes mellitus and collagen- linked fluorescence. N Engl J Med
314 : 403-408, 1986
6. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J,
Sivitz W, Monnier VM : Glycation and carboxymethyllysine




r p value r p value
Age 0.249 0.053 0.560 0.000
Duration of diabetes 0.162 0.214 0.256 0.046
Waist Circumference 0.078 0.553 0.045 0.730
BMI -0.098 0.451 -0.074 0.569
HbA1c 0.090 0.493 0.092 0.479
Glycated Albumin 0.123 0.344 -0.022 0.866
UAER -0.085 0.512 0.048 0.715
Serum creatinine 0.226 0.079 0.264 0.040
Pentosidine -0.086 0.511 0.041 0.753
eGFR -0.021 0.870 -0.226 0.080
Max-IMT NA NA 0.407 0.001
Systolic blood pressure 0.015 0.910 0.149 0.252
Diastolic blood pressure -0.132 0.312 -0.145 0.264
Total cholesterol -0.059 0.650 -0.194 0.135
Triglyceride -0.205 0.114 0.038 0.775
HDL-cholesterol 0.077 0.553 -0.219 0.091
LDL-cholesterol 0.220 0.881 -0.201 0.110
BMI ; body mass index, eGFR ; estimated glomerular filtration rate,
UAER ; urinary albumin excretion rate, AF ; autofluorescence, Max-IMT ;
maxim intima-media thickness in the carotid artery.
Figure 1. The correlation between MAX-IMT and AF
J. Temma, et al. Skin Autofluorescence and Atherosclerosis128
levels in skin collagen predict the risk of future 10-year pro-
gression of diabetic retinopathy and nephropathy in the diabe-
tes control and complications trial and epidemiology of diabe-
tes interventions and complications participants with type 1
diabetes. Diabetes 54 : 3103-3111, 2005
7. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW,
Gans RO, Smit AJ : Skin autofluorescence is a strong predic-
tor of cardiac mortality in diabetes. Diabetes Care 30 : 107-
112, 2007
8. Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW,
Hartog J, Gans R, Smit A : Simple noninvasive measurement of
skin autofluorescence. Ann N Y Acad Sci 1043 : 290-298, 2005
9. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ,
Gans RO, Smit AJ : Skin autofluorescence as a noninvasive
marker of vascular damage in patients with type 2 diabetes.
Diabetes Care 29 : 2654-2659, 2006
10. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH,
Smit AJ, Gans RO, Bilo HJ : Skin autofluorescence : a tool to
identify type 2 diabetic patients at risk for developing microvas-
cular complications. Diabetes Care 31 : 517-521, 2008
11. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ,
Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ : Sim-
ple non- invasive assessment of advanced glycation endproduct
accumulation. Diabetologia 47 : 1324-1330, 2004
12. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans
RO, Bilo HJ, Smit AJ : Skin autofluorescence provides ad-
ditional information to the UK Prospective Diabetes Study
(UKPDS) risk score for the estimation of cardiovascular progno-
sis in type 2 diabetes mellitus. Diabetologia 52 : 789-797, 2009
13. Katakami N, Kaneto H, Shimomura I : Carotid ultrasonogra-
phy : A potent tool for better clinical practice in diagnosis of
atherosclerosis in diabetic patients. J Diabetes Investig 5 : 3-13,
2014
14. Lutgers HL, Graaff R, de Vries R, Smit AJ, Dullaart RP : Carotid
artery intima media thickness associates with skin autofluo-
resence in non-diabetic subjects without clinically manifest
cardiovascular disease. Eur J Clin Invest 40 : 812-817, 2010
15. Koetsier M, Nur E, Chunmao H, Lutgers HL, Links TP, Smit
AJ, Rakhorst G, Graaff R : Skin color independent assessment
of aging using skin autofluorescence. Opt Express 18 : 14416-
14429, 2010
16. Kasami R, Kaneto H, Katakami N, Sumitsuji S, Yamasaki K,
Kuroda T, Tachibana K, Yasuda T, Kuroda A, Matsuoka TA,
Matsuhisa M, Shimomura I : Relationship between carotid
intima-media thickness and the presence and extent of coro-
nary stenosis in type 2 diabetic patients with carotid athero-
sclerosis but without history of coronary artery disease. Dia-
betes Care 34 : 468-470, 2011
17. Irie Y, Katakami N, Kaneto H, Kasami R, Sumitsuji S, Yamasaki
K, Tachibana K, Kuroda T, Sakamoto K, Umayahara Y, Ueda
Y, Kosugi K, Shimomura I : Maximum carotid intima-media
thickness improves the prediction ability of coronary artery
stenosis in type 2 diabetic patients without history of coronary
artery disease. Atherosclerosis 221 : 438-444, 2012
18. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL,
Smit A : The clinical relevance of assessing advanced glycation
end-products accumulation in diabetes. Cardiovasc Diabetol
7 : 29, 2008
19. Hricik DE, Wu YC, Schulak JA, Friedlander MA : Disparate
changes in plasma and tissue pentosidine levels after kidney
and kidney-pancreas transplantation. Clin Transplant 10 :
568-573, 1996
20. Katayama S, Moriya T, Tanaka S, Yajima Y, Sone H, Iimuro S,
Ohashi Y, Akanuma Y, Yamada N : Low transition rate from
normo- and low microalbuminuria to proteinuria in Japanese
type 2 diabetic individuals : the Japan Diabetes Complications
Study (JDCS). Diabetologia 54 : 1025-1031, 2011
21. Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M,
Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A : Reduction
in microalbuminuria as an integrated indicator for renal and
cardiovascular risk reduction in patients with type 2 diabetes.
Diabetes 56 : 1727-1730, 2007
The Journal of Medical Investigation Vol. 62 August 2015 129
